MARK MCAFEE: Open Payments
NPI 1487410122 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 73 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,394 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $247 |
| Aimmune Therapeutics, Inc. | 9 | $230 |
| Celltrion USA Inc. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $138 |
| Ardelyx, Inc. | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Janssen Biotech, Inc. | 3 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Gilead Sciences, Inc. | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
Products named: ZENPEP, RINVOQ, VEGZELMA, ENTYVIO, IBSRELA, DUPIXENT, TREMFYA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
